An increased level of sHLA-G has been observed in breast cancer (Chen et al., 2010), prostate cancer (Heidari et al., 2017), colorectal, gastric, esophageal and lung cancers (Cao et al., 2011) patients. This evidence concerns the gene HLA-G and breast carcinoma.